| scholarly article | Q13442814 |
| P356 | DOI | 10.1046/J.1365-2036.2003.01738.X |
| P953 | full work available at URL | https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2036.2003.01738.x |
| https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2036.2003.01738.x | ||
| P698 | PubMed publication ID | 14535878 |
| P5875 | ResearchGate publication ID | 9057784 |
| P50 | author | Silvia Pastoreková | Q89741321 |
| P2093 | author name string | J. Chen | |
| H-U Kasper | |||
| U. Kellner | |||
| Z. Tulassay | |||
| P. Malfertheiner | |||
| U. Lendeckel | |||
| M. Juhász | |||
| M. P A. Ebert | |||
| P2860 | cites work | Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. | Q53388568 |
| Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma | Q57377955 | ||
| Carbonic anhydrase inhibitors - Part 94. 1,3,4-Thiadiazole-2-sulfonamide derivatives as antitumor agents? | Q58863328 | ||
| Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix | Q59139010 | ||
| An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53 | Q67539546 | ||
| Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma | Q71102409 | ||
| Expression of thrombospondin-1 in pancreatic carcinoma: correlation with microvessel density | Q73626667 | ||
| Pattern of distribution and prognostic value of angiogenesis in pancreatic duct carcinoma: a semiquantitative immunohistochemical study of 45 patients | Q73725386 | ||
| Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis | Q73954444 | ||
| Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma | Q74128408 | ||
| MN/CA9 gene expression as a potential biomarker in renal cell carcinoma | Q77879943 | ||
| Implications of growth factor alterations in the treatment of pancreatic cancer | Q24800145 | ||
| Carbonic anhydrase in human pancreas: hypotheses for the pathophysiological roles of CA isozymes | Q28140370 | ||
| The catalytic properties of human carbonic anhydrase IX | Q28202087 | ||
| A novel quasi-viral agent, MaTu, is a two-component system | Q28209256 | ||
| Immunohistochemistry of carbonic anhydrase isozyme IX (MN/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity | Q28266273 | ||
| Expression of MaTu-MN protein in human tumor cultures and in clinical specimens | Q28268829 | ||
| Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts | Q28303168 | ||
| Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro | Q35051535 | ||
| Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. | Q35746400 | ||
| Examining the technique of angiogenesis assessment in invasive breast cancer | Q36431247 | ||
| A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. | Q38476637 | ||
| Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation | Q41372688 | ||
| Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation | Q42148565 | ||
| MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas | Q42279835 | ||
| MN antigen expression in normal, preneoplastic, and neoplastic esophagus: a clinicopathological study of a new cancer-associated biomarker | Q42439841 | ||
| Carbonic anhydrase IX antigen differentiates between preneoplastic malignant lesions in non-small cell lung carcinoma | Q42480291 | ||
| Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor | Q44223664 | ||
| High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. | Q53312459 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 837-846 | |
| P577 | publication date | 2003-10-01 | |
| 2003-10-15 | |||
| P1433 | published in | Alimentary Pharmacology & Therapeutics | Q4726656 |
| P1476 | title | Expression of carbonic anhydrase IX in human pancreatic cancer | |
| P478 | volume | 18 |
| Q37236890 | A novel epigenetic CREB-miR-373 axis mediates ZIP4-induced pancreatic cancer growth |
| Q28610062 | Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression |
| Q38265305 | Acid-base transport in pancreatic cancer: molecular mechanisms and clinical potential. |
| Q38154554 | Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases |
| Q36816042 | Circulating oncoproteins HER2/neu, EGFR and CAIX (MN) as novel cancer biomarkers |
| Q39254783 | Down regulation of CAII is associated with tumor differentiation and poor prognosis in patients with pancreatic cancer |
| Q42575789 | Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts |
| Q37690276 | Evaluation of Nonpeptidic Ligand Conjugates for SPECT Imaging of Hypoxic and Carbonic Anhydrase IX-Expressing Cancers |
| Q37710994 | Evaluation of a Carbonic Anhydrase IX-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Hypoxic Tumors |
| Q36640466 | Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia |
| Q35597597 | Expression of carbonic anhydrase 9 at the invasion front of gastric cancers |
| Q36572752 | Hypoxia and angiogenesis in pancreatic cancer. |
| Q40487746 | Increased expression of ADAM family members in human breast cancer and breast cancer cell lines |
| Q33856008 | Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer |
| Q58863293 | Modulation of carbonic anhydrase activity and its applications in therapy |
| Q37250091 | Near-Infrared Fluorescence Imaging of Carbonic Anhydrase IX in Athymic Mice Bearing HT-29 Tumor Xenografts |
| Q60922158 | Prostate cancer cells and exosomes in acidic condition show increased carbonic anhydrase IX expression and activity |
| Q38734017 | Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models |
| Q50531648 | Roles of Carbonic Anhydrase IX in Development of Pancreatic Cancer. |
| Q96132757 | SLC39A4 as a Novel Prognosis Marker Promotes Tumor Progression in Esophageal Squamous Cell Carcinoma |
| Q36546587 | Sulfonamide derivative targeting carbonic anhydrase IX as a nuclear imaging probe for colorectal cancer detection in vivo |
| Q37295258 | Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer |
| Q55712021 | Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma. |
| Q33737752 | ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. |
| Q36413357 | ZIP4 silencing improves bone loss in pancreatic cancer |
Search more.